Honduras vs Netherlands: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Honduras
- Netherlands
How they compare
Honduras currently reports 839.71 deaths against 754.52 deaths in Netherlands, a difference of 85.19 deaths.
That makes Honduras's figure about 1.1 times Netherlands's.
The two have swapped places 1 time across 34 shared years of data; in 1990 it was Netherlands ahead.
Honduras ranks 78th and Netherlands ranks 81st of 157 countries.
Across the 4 decades both report, Honduras averaged higher in 2 and Netherlands in 2.
Head to head by decade
| Decade | Honduras | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 194.11 deaths | 194.11 deaths | Netherlands |
| 2000s | 578.33 deaths | 651.7 deaths | 73.36 deaths | Netherlands |
| 2010s | 1,022 deaths | 818.94 deaths | 202.98 deaths | Honduras |
| 2020s | 859.76 deaths | 771.54 deaths | 88.22 deaths | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Honduras or Netherlands?
- Honduras, at 839.71 deaths against 754.52 deaths in Netherlands as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Honduras and Netherlands?
- 85.19 deaths, with Honduras ahead.
- How many years of comparable data are there for Honduras and Netherlands?
- 34 years are reported by both, from 1990 to 2023.
- How do Honduras and Netherlands rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Honduras ranks 78th and Netherlands ranks 81st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.